EMV current MC $187mil / $2.19 SP If EMV at $21bil MC = $247 per share
COH was established in the 1980s, and lingered around EMV's current MC until 1998 where it jumped 10-20x and ranged there for several years. The timing and significance of the events in 1998 coincided with the FDA approval of the CI24M implant.
The next leg up occurred in 2015 when the FDA approved the Nucleus Profile implant - MC jumped to ~50x (based on EMV's current levels) and lingered a few more years before the ATH this year.
I am certainly not comparing apples for apples here, and it will be impossible to do so. But some approximate metrics may assist in painting some sort of forecast over the next few months.
Prevalidation clinical trials nearly complete, and Validation clinical trial underway going into early 2025. A reasonable expectation would be to see regulatory approvals in some parts of the world from H2 2025.
Regulatory approval = big money coming in
Stroke is the 2nd leading cause of death worldwide. Annually, 15 mil people suffer a stroke. How many people get a cochlear implant each year?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)